10 months) tended to have a longer PFS, although this did not reach statistical significance (Fig. 1 , Supplementary Fig.
← all excerpts
Combined elevation of pre-treatment γ-glutamyltransferase and lactate dehydrogenase as independent prognosticator for metastatic renal cell carcinoma undergoing immune-based therapy.
1
—
—